Group One Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,925,400
| Closed | -$1.38M | – | 5251 |
|
|
2016
Q3 | $1.38M | Sell |
3,925,400
-178,300
| -4% | -$62.5K | 0.01% | 1067 |
|
|
2016
Q2 | $1.91M | Buy |
4,103,700
+449,800
| +12% | +$210K | 0.02% | 849 |
|
|
2016
Q1 | $4.97M | Buy |
3,653,900
+2,890,600
| +379% | +$3.93M | 0.07% | 342 |
|
|
2015
Q4 | $1.12M | Buy |
763,300
+32,100
| +4% | +$47.2K | 0.01% | 1241 |
|
|
2015
Q3 | $1.16M | Sell |
731,200
-329,400
| -31% | -$520K | 0.02% | 1141 |
|
|
2015
Q2 | $1.8M | Buy |
1,060,600
+345,900
| +48% | +$588K | 0.03% | 814 |
|
|
2015
Q1 | $993K | Buy |
714,700
+42,300
| +6% | +$58.8K | 0.02% | 1091 |
|
|
2014
Q4 | $1.01M | Sell |
672,400
-163,100
| -20% | -$246K | 0.02% | 1067 |
|
|
2014
Q3 | $1.72M | Sell |
835,500
-344,500
| -29% | -$710K | 0.03% | 775 |
|
|
2014
Q2 | $3.61M | Sell |
1,180,000
-286,400
| -20% | -$876K | 0.06% | 399 |
|
|
2014
Q1 | $3.67M | Buy |
1,466,400
+355,700
| +32% | +$889K | 0.06% | 338 |
|
|
2013
Q4 | $5.51M | Buy |
1,110,700
+656,600
| +145% | +$3.26M | 0.08% | 233 |
|
|
2013
Q3 | $1.03M | Buy |
454,100
+337,400
| +289% | +$766K | 0.02% | 996 |
|
|
2013
Q2 | $259K | Buy |
+116,700
| New | +$259K | 0.01% | 1919 |
|
Group One Trading's RXII Position: Q4 2016 in Review
Group One Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 135,018 shares — an estimated $47K sold.
Group One Trading first reported a position in RXII in Q1 2014 and held it in 10 quarters. The position peaked at $2M in Q3 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Group One Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Group One Trading sold 135,018 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $47K.
- Group One Trading first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 10 quarters.
- Group One Trading's GALENA BIOPHARMA INC COM position peaked at $2M in Q3 2015.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.